MetaCap

Carlsmed (CARL) vs Cerus (CERS)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Carlsmed (CARL) has outperformed Cerus (CERS) over the past year, gaining 39.5% versus a gain of 14.2%. Carlsmed is the larger company by market cap ($477.4 million vs $373.6 million), about 1.3 times the size. Cerus converts more of its revenue into profit, with a net margin of -6.7% versus -58.7%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CARL+39.47%CERS+14.20%
+109%+37%-36%
Nov 21, 20251 yearNov 20, 2026
CARL+20.14%CERS+33.09%
+136%+44%-47%
Jul 21, 20255 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CARL versus CERS key metrics
MetricCARLCERS
Share price$17.42$1.85
Market cap$477.38M$373.62M
1-day change+1.16%-2.63%
YTD return+41.05%-10.19%
1-year return+39.47%+14.20%
5-year return—-73.50%
Forward P/E—123.33
EPS (TTM)$-1.13$-0.04
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$50.51M$233.80M
Revenue growth (YoY)+85.94%+16.13%
Net income (latest FY)$-29.63M$-15.63M
Gross margin75.31%—
Operating margin-60.53%-3.71%
Net margin-58.67%-6.68%
52-week high$19.15$3.47
52-week low$8.50$1.59
Distance from 52-week high-9.05%-46.69%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+26.29%+177.30%
Average volume112.80K2.12M
Shares outstanding27.40M201.95M
Employees127261
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • CARL has outperformed CERS by 25.3 percentage points over the past year.
  • Cerus is more profitable, keeping -6.7 cents of every revenue dollar as net income versus -58.7 cents for Carlsmed.
  • Carlsmed grew revenue faster in its latest fiscal year (+85.94% vs +16.13%).

About Carlsmed

CARL stock →

Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures.

Health Care · Medical/Dental Instruments · 127 employees

About Cerus

CERS stock →

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety.

Health Care · Medical/Dental Instruments · 261 employees

CARL vs CERS FAQ

Which is bigger, Carlsmed or Cerus?

Carlsmed (CARL) is larger, with a market capitalization of $477.38M compared with $373.62M for Cerus (CERS).

Which stock has performed better over the past year, CARL or CERS?

CARL returned +39.47% over the past 12 months, compared with +14.20% for CERS (price return, excluding dividends). Past performance does not predict future results.

Are Carlsmed and Cerus in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons